Flad Architects

The National Bio and Agro-Defense Facility (NBAF) opened in May of 2023 in Manhattan, Kan. Enabling the rapid detection and mitigation of animal and human pathogens, the $1.25 billion complex provides state-of-the-art biocontainment labs supported by robust ventilation and decontamination systems. Sited on 48 acres adjacent to Kansas State University, the 708,000-sf development provides enhanced diagnostic and research capabilities to protect the country from emerging, zoonotic, and foreign animal diseases.

Longfellow Real Estate Partners broke ground in February of 2023 on Avia Labs in Millbrae, Calif. Designed by Flad Architects, the 479,000-sf life science facility will provide 315,000 rsf of Class A lab and office space arranged in a 50:50 ratio. The six-story building will also house state-of-the-art conference rooms, a fitness center, and a publicly accessible café. JLL has secured a $310 million construction loan for the project, which will integrate an advanced HVAC system supplying 12 air changes per hour.

Amgen opened a 245,000-sf R&D center in South San Francisco in October of 2022. Located on the Gateway of Pacific life sciences campus in Oyster Point, the leased facility was designed by Flad Architects and developed by BioMed Realty. Featuring modular wet and molecular labs, the nine-story tower accommodates Amgen's research programs in oncology, inflammation, and cardiometabolic diseases. Flexible floor plates integrate lab and office functions, with open work spaces and movable furnishings promoting collaboration and interaction.

New York’s largest healthcare provider is adapting to evolving research demands by making its Feinstein Institutes for Medical Research more conducive to the needs of today’s researchers and those hired in the future, by increasing lab capacity and efficiency, upgrading infrastructure, repurposing underutilized space, and incorporating flexibility to accommodate facility modifications for many years. The renovation is the beginning of a multi-faceted approach to support the institute’s strategy for growth.

AbbVie opened a 480,000-sf biomedical research center in South San Francisco in April of 2022. Offering state-of-the-art laboratories and collaborative workspaces, the leased facility will accelerate the discovery and commercialization of new cancer therapeutics. As the anchor tenant for the Gateway of Pacific’s first phase of construction, AbbVie occupies 11 contiguous floors in the 12-story structure.